Insiders Akari Therapeutics, Plc

Equities

AKTX

US00972G2075

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.185 ^USD	-0.42%		+1.61%	-62.02%

Apr. 24	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Akari Therapeutics Appoints Samir R. Patel, M.D. to Board of Directors	Dec. 01	CI
Akari Therapeutics, Plc Announces Appointment of Beth-Anne Lang as Senior Vice President, Regulatory Affairs, Effective September 1, 2023	23-08-03	CI
Akari Therapeutics Names Wendy DiCicco Interim Finance Chief	23-07-19	MT
Akari Therapeutics, plc Announces Appointment of Wendy Dicicco as Interim Chief Financial Officer	23-07-19	CI
Akari Therapeutics, plc Announces Management Appointments	23-07-05	CI
Aspira Women's Health Names Torsten Hombeck as Chief Financial Officer, Effective June 15	23-05-16	MT
Akari Therapeutics Announces the Appointment of John F. Neylan, III as Executive Vice President, Chief Medical Officer	22-11-08	CI
Akari Therapeutics Names Melissa Bradford-Klug COO	22-06-13	MT
Akari Therapeutics, Plc Appoints Melissa Bradford-Klug as Chief Operating Officer, Effective July 1, 2022	22-06-13	CI
Akari Therapeutics Appoints Rachelle Jacques as President, CEO	22-03-02	MT
Akari Therapeutics, Plc Appoints Rachelle Jacques as President and Join its Board of Directors	22-03-02	CI
Akari Therapeutics, plc Announces Chief Executive Officer Changes	22-03-02	CI
Akari Therapeutics, plc Appoints Sanjeev Khindri as New Senior Medical Director	21-06-29	CI
Akari Therapeutics, plc Appoints Torsten Hombeck as Member of the Executive Team	20-07-01	CI
Akari Therapeutics, Plc Appoints Torsten Hombeck as Chief Financial Officer	20-07-01	CI
Akari Therapeutics, plc Appoints as Permanent Chief Executive Officer from Interim Chief Executive Officer	19-08-29	CI
Akari Therapeutics, plc Announces Management Changes, with Effect from May 08, 2018	18-05-11	CI
Akari Therapeutics, Plc Announces Board Appointments	18-01-23	CI
Akari Therapeutics, Inc. Terminates Robert Shaw as Chief Legal & Compliance Officer and Company Secretary	17-12-08	CI
Akari Therapeutics Announces Appointment of David Horn Solomon as Chief Executive Officer, Effective August 28, 2017	17-08-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Akari Therapeutics, Plc

Equities

AKTX

US00972G2075

Insiders

Filters